» Articles » PMID: 11978148

Electrocardiographic and Hemodynamic Effects of Panax Ginseng

Overview
Specialty Pharmacology
Date 2002 Apr 30
PMID 11978148
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether Panax ginseng ingestion can acutely or chronically alter electrocardiographic parameters: PR, QRS, QT, QTc, and RR intervals, and QT and QTc interval dispersion. Effects of P. ginseng on blood pressure and heart rate also were evaluated.

Methods: This is a prospective, randomized, double-blind, placebo-controlled study of healthy adults at the University of Connecticut. Thirty subjects were randomly allocated to receive 28 days of therapy with either P. ginseng extract 200 mg or placebo. Baseline 12-lead electrocardiograms (ECGs) were obtained. Subsequent ECGs were performed following study drug ingestion at 50 minutes, 2 hours, and 5 hours on days 1 and 28. Blood pressure readings were taken with each ECG.

Results: P. ginseng ingestion increased the QTc interval by 0.015 seconds on day 1 at 2 hours compared with the placebo group (p = 0.03). It also reduced diastolic blood pressure from 75 +/- 5 mm Hg at baseline to 70 +/- 6 mm Hg at the same time point (p = 0.02). The observed effects are not believed to be clinically significant. No other statistically significant changes were found in electrocardiographic or hemodynamic variables on days 1 or 28.

Conclusions: P. ginseng, at doses of 200 mg of the extract daily, increases the QTc interval and decreases diastolic blood pressure 2 hours after ingestion in healthy adults on the first day of therapy.

Citing Articles

Therapeutic mechanisms of ginseng in coronary heart disease.

Tang M, Zhao S, Li R, Hou W Front Pharmacol. 2023; 14:1271029.

PMID: 37854713 PMC: 10579605. DOI: 10.3389/fphar.2023.1271029.


Ginseng extract and ginsenosides improve neurological function and promote antioxidant effects in rats with spinal cord injury: A meta-analysis and systematic review.

Sng K, Li G, Zhou L, Song Y, Chen X, Wang Y J Ginseng Res. 2022; 46(1):11-22.

PMID: 35058723 PMC: 8753526. DOI: 10.1016/j.jgr.2021.05.009.


A comprehensive quality analysis of randomized controlled clinical trials of Asian ginseng and American ginseng based on the CONSORT guideline.

Chen W, Li X, Chen Z, Hao W, Yao P, Li M J Ginseng Res. 2022; 46(1):71-78.

PMID: 35035241 PMC: 8753457. DOI: 10.1016/j.jgr.2021.05.003.


Ginseng: A bibliometric analysis of 40-year journey of global clinical trials.

Chen W, Yao P, Vong C, Li X, Chen Z, Xiao J J Adv Res. 2022; 34:187-197.

PMID: 35024190 PMC: 8655123. DOI: 10.1016/j.jare.2020.07.016.


Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Karmazyn M, Gan X Mol Cell Biochem. 2020; 476(1):333-347.

PMID: 32940821 DOI: 10.1007/s11010-020-03910-8.